Government: Domestic Pharmaceutical Companies to Begin Overseas Vaccine Contract Manufacturing from August

"Specific vaccine types cannot be disclosed"

[Image source=Yonhap News]

[Asia Economy Reporter Kim Ji-hee] A domestic pharmaceutical company will begin contract manufacturing of overseas COVID-19 vaccines starting in August.

Baek Young-ha, head of the government-wide Vaccine Introduction Task Force (TF) Vaccine Introduction General Team, stated at the COVID-19 vaccine briefing on the 15th, "A domestic pharmaceutical company is in the process of finalizing a specific contract for the production of vaccines approved overseas," adding, "From August, the vaccine will be mass-produced domestically." However, regarding which pharmaceutical company will produce which type of vaccine, he said, "Since it is a contractual matter, it is difficult to provide detailed information."

Team leader Baek said, "Although uncertainty is increasing worldwide due to unstable vaccine supply, our country has relatively less uncertainty thanks to the domestic production base," and added, "We will proceed with the goal of herd immunity in November without setbacks."

This content was produced with the assistance of AI translation services.